A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

Clinical trial NCT07231029 · RECRUITING

Trial details

NCT number: NCT07231029
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Mild or Moderate Hepatic Impairment

Start date: 2025-12-23
Primary completion: 2026-10-26
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.